Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
oseltamivir (tamiflu) (2 trials)
Metabolic Diseases (Phase 4)
Trials (2 total)
Trial APIs (1 total)